Diebold Nixdorf (DBD) Misses Q3 EPS by 51c; unchanged guidance
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $84.56 --0%
EPS Growth %: +30.9%
Financial Fact:
Selling and administrative expense: 127.3M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +30.9%
Financial Fact:
Selling and administrative expense: 127.3M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q3 EPS of $0.53, $0.51 worse than the analyst estimate of $1.04. Revenue for the quarter came in at $927.1 million versus the consensus estimate of $954.86 million.
GUIDANCE
Full-Year 2024 Financial Outlook (unchanged from previous guidance)
Total Revenue- Flat
Adjusted EBITDA $435M - $450M
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Advance Goods Trade Balance (May) -$105.8B vs -$85B Expected
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
